Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

Blood Cancer Journal - United States
doi 10.1038/bcj.2016.113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal
Medicine
2010English

Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized Hovon-Nordic Lymphoma Group Phase Iii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma

2020English

High-Risk Patients With Diffuse Large B-Cell Lymphoma Are Not Enrolled on Clinical Trials

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Outcome Prediction in Diffuse Large B-Cell Lymphoma Can Be Greatly Improved by Alternative Use of Clinical Information: A Nordic Lymphoma Group Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Primary Breast Diffuse Large B-Cell Lymphoma. Clinical Features and Outcome in 55 Patients. Polish Lymphoma Research Group Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma: A Case Report

Clinical and Experimental Health Sciences
2018English

Vitreoretinal Lymphoma Followed by Systemic Diffuse Large B Cell Lymphoma

Journal of Ophthalmic Inflammation and Infection
OphthalmologyInfectious Diseases
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy